Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review
Laxman Singh, Shikha Sharma, Suowen Xu, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 4036-4036
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The Role of Oxidative Stress in Atherosclerosis
Matthew Batty, Martin R. Bennett, Emma Yu
Cells (2022) Vol. 11, Iss. 23, pp. 3843-3843
Open Access | Times Cited: 241
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
Lenka Koklesová, Alena Mazuráková, Marek Samec, et al.
The EPMA Journal (2021) Vol. 12, Iss. 4, pp. 477-505
Open Access | Times Cited: 123
Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives
Md. Rezaul Islam, Abdur Rauf, Shopnil Akash, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116034-116034
Open Access | Times Cited: 52
Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials
Timothy Panknin, Carol Howe, Meg Hauer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4476-4476
Open Access | Times Cited: 50
Targeting endothelial vascular cell adhesion molecule-1 in atherosclerosis: drug discovery and development of vascular cell adhesion molecule-1–directed novel therapeutics
Jessica R Pickett, Yuao Wu, Lucía F. Zacchi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 13, pp. 2278-2293
Open Access | Times Cited: 44
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment
Caroline Bertoncini‐Silva, Adelina Vlad, Roberta Ricciarelli, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 331-331
Open Access | Times Cited: 39
Longevity and anti-aging effects of curcumin supplementation
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2933-2950
Open Access | Times Cited: 19
Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process
Marco Munno, Alice Mallia, Arianna Greco, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 583-583
Open Access | Times Cited: 17
Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
Zhaohui Gong, Haixin Yang, Li Gao, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Curcumin in Metabolic Health and Disease
Marzena Jabczyk, Justyna Nowak, Bartosz Hudzik, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4440-4440
Open Access | Times Cited: 95
Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets
Mandy O. J. Grootaert, Martin R. Bennett
Nature Reviews Cardiology (2022) Vol. 19, Iss. 10, pp. 668-683
Closed Access | Times Cited: 59
The Modulatory Effects of Curcumin on the Gut Microbiota: A Potential Strategy for Disease Treatment and Health Promotion
Junwen Zhu, Lan He
Microorganisms (2024) Vol. 12, Iss. 4, pp. 642-642
Open Access | Times Cited: 9
Recent advances of traditional Chinese medicine for the prevention and treatment of atherosclerosis
Wenbing Zhi, Yang Liu, Xiumei Wang, et al.
Journal of Ethnopharmacology (2022) Vol. 301, pp. 115749-115749
Open Access | Times Cited: 34
NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics
Na Lu, Weijia Cheng, Dongling Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 31
Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress
Xiaolu Zhang, Yujia Zheng, Ziyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115475-115475
Open Access | Times Cited: 21
Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis
Rasmita Dash, Madhulika Yadav, Jyotirmaya Biswal, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123009-123009
Closed Access | Times Cited: 19
Natural Antioxidant‐Based Nanodrug for Atherosclerosis Treatment
Xiaoluan Lu, Zhongshan He, Xiao Xiao, et al.
Small (2023) Vol. 19, Iss. 49
Open Access | Times Cited: 17
Targeting transforming growth factor‐ß signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin
Devesh Tewari, Anu Priya, Anusha Bishayee, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 28
Natural AMPK Activators in Cardiovascular Disease Prevention
Reza Heidary Moghaddam, Zeinab Samimi, Sedigheh Asgary, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 23
Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy
Mengran Guo, Shugang Qin, Shiyan Wang, et al.
Molecules (2023) Vol. 28, Iss. 17, pp. 6370-6370
Open Access | Times Cited: 16
Curcumin in treatment of hematological cancers: Promises and challenges
Maliheh Entezari, Armita Tayari, Mahshid Deldar Abad Paskeh, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 2, pp. 121-134
Open Access | Times Cited: 6
Curcumin-Based Fixed Dose Combination Products for Cholesterol Management: A Narrative Review
Alberto Boretti
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 300-308
Closed Access | Times Cited: 5
Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management
Agustina Dwi Retno Nurcahyanti, Fonny Cokro, Martha P. Wulanjati, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 22
The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications
M Alam, Md Jamir Anwar, Manish Kumar Maity, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1674-1674
Open Access | Times Cited: 4
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most?
Stanisław Surma, Amirhossein Sahebkar, Jakub Urbański, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top